Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Merit Medical Systems, Inc. (NASDAQ:MMSI) has been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have issued a buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $92.80.

A number of brokerages have weighed in on MMSI. Needham & Company LLC decreased their target price on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company reduced their price target on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Robert W. Baird set a $83.00 price target on shares of Merit Medical Systems in a research report on Friday, May 1st. Canaccord Genuity Group reduced their price target on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, Piper Sandler reduced their price target on shares of Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research report on Friday, April 17th.

Insider Activity at Merit Medical Systems

In related news, Director Lynne N. Ward sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the sale, the director owned 7,809 shares of the company’s stock, valued at $488,921.49. This trade represents a 39.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brian G. Lloyd purchased 2,000 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average cost of $62.62 per share, with a total value of $125,240.00. Following the transaction, the insider directly owned 2,000 shares of the company’s stock, valued at $125,240. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Merit Medical Systems

Several institutional investors and hedge funds have recently made changes to their positions in MMSI. Tudor Investment Corp ET AL bought a new stake in shares of Merit Medical Systems during the third quarter valued at approximately $2,913,050,000. Wellington Management Group LLP grew its position in Merit Medical Systems by 377.7% in the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after purchasing an additional 980,823 shares during the period. Norges Bank bought a new stake in Merit Medical Systems in the 4th quarter worth approximately $75,957,000. Thrivent Financial for Lutherans grew its position in Merit Medical Systems by 250.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 750,066 shares of the medical instruments supplier’s stock worth $62,428,000 after purchasing an additional 536,072 shares during the period. Finally, Iron Triangle Partners LP bought a new stake in Merit Medical Systems in the 4th quarter worth approximately $33,992,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $64.17 on Monday. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $97.18. The company has a 50 day simple moving average of $66.86 and a two-hundred day simple moving average of $77.72. The company has a market capitalization of $3.83 billion, a price-to-earnings ratio of 27.78, a P/E/G ratio of 2.00 and a beta of 0.58. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The business had revenue of $381.88 million during the quarter, compared to the consensus estimate of $377.59 million. During the same quarter last year, the firm earned $0.86 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Analysts expect that Merit Medical Systems will post 3.61 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.